NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,883 Cr | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹442 Cr |
What is the latest Profit After Tax of NATCO PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹1,883 Cr |
| Mar2024 | ₹1,388 Cr |
| Mar2023 | ₹715 Cr |
| Mar2022 | ₹170 Cr |
| Mar2021 | ₹442 Cr |
How is Profit After Tax of NATCO PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,883 Cr | 35.66 | |
| Mar2024 | ₹1,388 Cr | 94.09 | |
| Mar2023 | ₹715 Cr | 320.76 | |
| Mar2022 | ₹170 Cr | -61.57 | |
| Mar2021 | ₹442 Cr | - | |
Compare Profit After Tax of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,471.6 Cr | -0.6% | -26.4% | -1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.6% |
-26.4% |
-1.9% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses